Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome
Globe Newswire•18/09/2026•06:10 ET
0
Get started
Create a free account to read the full story and Whiz Insights.
Create a free account to read the full story and Whiz Insights.